NL-OMON55704已完成3 期
Semaglutide effects on cardiovascular outcomes in people with overweight or obesity - SELECT
ovo Nordisk0 个研究点目标入组 250 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •* Male or female, age >= 45 years at the time of signing informed consent
- •* Body mass index (BMI) >= 27 kg/m2
- •* Have established CV disease as evidenced by at least one of the following:
- •prior myocardial infarction, prior stroke (ischemic and hemorrhagic stroke) or
- •symptomatic peripheral arterial disease (PAD, as evidenced by intermittent
- •claudication with ankle-brachial index (ABI) < 0.85 (at rest), or peripheral
- •arterial revascularization procedure, or amputation due to atherosclerotic
排除标准
- •*Any of the following: myocardial infarction, stroke, hospitalisation for
- •unstable angina pectoris
- •or transient ischaemic attack within the past 60 days prior to the day of
- •* HbA1c >= 48 mmol/mol (6.5%) as measured by the central laboratory at screening
- •* History of type 1 or type 2 diabetes (history of gestational diabetes is
研究者
相似试验
进行中（未招募）
3 期
A randomised, double-blind, parallel group, placebo-controlled trial comparing semaglutide 2.4 mgwith semaglutide placebo both administered s.c. once-weekly in subjects with established CVdisease and overweight or obesityCTRI/2018/10/016193ovo Nordisk AS
进行中（未招募）
1 期
SELECT - Semaglutide effects on heart disease and stroke in patients with overweight or obesityEUCTR2017-003380-35-HUovo Nordisk Hungária Kft.17,500
进行中（未招募）
1 期
SELECT - Semaglutide effects on heart disease and stroke in patients with overweight or obesityOverweightObesityMedDRA version: 24.1Level: PTClassification code 10033307Term: OverweightSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 20.0Level: PTClassification code 10029883Term: ObesitySystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2017-003380-35-BGovo Nordisk A/S17,500
进行中（未招募）
1 期
SELECT - Semaglutide effects on heart disease and stroke in patients with overweight or obesityEUCTR2017-003380-35-BEovo Nordisk A/S17,500
进行中（未招募）
1 期
SELECT - Semaglutide effects on heart disease and stroke in patients with overweight or obesityEUCTR2017-003380-35-CZovo Nordisk A/S17,500